Welcome to the Epidemic Preparedness Innovations (EPI) web space. This platform has been set up by the Coalition for Epidemic Preparedness Innovations (CEPI). It aims to bring together knowledge, tools and methods to support vaccine researchers, developers, funders and anybody working on or interested in the field of epidemic preparedness innovations.
Q&A session re RfP Partnership for preparing clinical trial sites for a GCP-compliant Ph 3 Lassa fever vaccine efficacy trial & long-term epidemic research preparedness in West Africa (hosted by TGHN). Click on 'Read More' to view on YouTube Read more
Q&A sessions re RfP Partnership for preparing clinical trial sites for a GCP-compliant Ph 3 Lassa fever vaccine efficacy trial & long-term epidemic research preparedness in West Africa. Click on 'Read More' to view on TGHN's Events page Read more
CEPI is seeking a consortium led by a Technical Coordinating Partner (lead applicant) for preparing clinical trial sites for a GCP-compliant Phase 3 Lassa fever vaccine efficacy trial and long-term epidemic research preparedness in West Africa. Read more
CEPI and EFPIA collaborated to author a regulatory position paper on master files in the EU. A new “Pharmaceutical Master File” overarching model is proposed that encompasses existing master files procedures as well as expanded approaches not in place today. ... Read more
The Enable Lassa Research Programme is a prospective multi-site cohort study to estimate incidence of infection and disease due to Lassa fever virus, following 23,000 participants across five West African countries. To discuss the interim results of the Enable study ... Read more
Renewed partnership will broaden the scope of SPEAC to deliver world-leading vaccine safety guidance & support for CEPI’s mission to compress development of new vaccines against pathogens with pandemic potential to 100 days Read more
This news announcement forms part of CEPI’s 100 Days Mission, a campaign delving into how we can compress the vaccine development timeline to 100 days, while also counting down to CEPI’s Global Pandemic Preparedness Summit taking place in March, 2022. ... Read more
COVID-19 has touched all of our lives and changed our world beyond recognition. What comes next? ... Read more
See more here... Read more
Earlier this century, two inter-related randomised controlled trials—the first in southeast Asia and a second in Africa—provided an incontrovertible breakthrough in the treatment of severe falciparum malaria. The trials, of ...
Background Racism is a social determinant of health inequities. In Brazil, racial injustices lead to poor outcomes in maternal and child health for Black and Indigenous populations, including greater risks ...
This summary document focusses on Long COVID, also known as post-COVID syndrome or post-acute COVID-19, in the context of clinical development and vaccine efficacy trials. Long COVID is typically assessed ...
